These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9116353)

  • 1. Remarks of Louis W. Sullivan, MD, before the annual AIMBE meeting.
    Sullivan LW
    ASAIO J; 1997; 43(1):5-7. PubMed ID: 9116353
    [No Abstract]   [Full Text] [Related]  

  • 2. Remarks by Louis W. Sullivan, MD, Secretary of Health and Human Services, at the sixth annual meeting of the Association for Academic Minority Physicians, October 23-25, 1992, Washington, DC.
    Sullivan LW
    J Assoc Acad Minor Phys; 1993; 4(1):11-3. PubMed ID: 8425099
    [No Abstract]   [Full Text] [Related]  

  • 3. Remarks by Louis W. Sullivan, MD Secretary of Health and Human Services at the annual meeting of the Association for Academic Minority Physicians October 28, 1989, Washington, D.C.
    Sullivan LW
    J Assoc Acad Minor Phys; 1990; 1(2):7-9. PubMed ID: 2135696
    [No Abstract]   [Full Text] [Related]  

  • 4. A look at medical devices.
    Byers TE
    Proc Rudolf Virchow Med Soc City N Y; 1965; 24():8-14. PubMed ID: 5260826
    [No Abstract]   [Full Text] [Related]  

  • 5. The future of medical device development in the United States.
    Utley JR
    ASAIO J; 1997; 43(1):1-4. PubMed ID: 9116342
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA "reform"?
    Miller HI
    Science; 1998 Jan; 279(5348):158-9. PubMed ID: 9446215
    [No Abstract]   [Full Text] [Related]  

  • 7. Remarks at the Food and Drug Law Institute's 48th Annual Conference.
    Niedelman SM
    Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs, devices, diagnostics, and policies: the year's review.
    Kupecz D
    Nurse Pract; 2000 Feb; 25(2):42, 45-8, 51-3; quiz 54-5. PubMed ID: 10703024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label use of drugs and medical devices: a review of policy implications.
    Stafford RS
    Clin Pharmacol Ther; 2012 May; 91(5):920-5. PubMed ID: 22472990
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical device development: from prototype to regulatory approval.
    Kaplan AV; Baim DS; Smith JJ; Feigal DA; Simons M; Jefferys D; Fogarty TJ; Kuntz RE; Leon MB
    Circulation; 2004 Jun; 109(25):3068-72. PubMed ID: 15226221
    [No Abstract]   [Full Text] [Related]  

  • 11. Dr Louis W Sullivan--Secretary of Health and Human Services, USA. Interview by Dieter JR Pohl.
    Sullivan LW
    World Hosp; 1991; 27(3):36-40. PubMed ID: 10123002
    [No Abstract]   [Full Text] [Related]  

  • 12. Despite research, FDA says marijuana has no benefit.
    Twombly R
    J Natl Cancer Inst; 2006 Jul; 98(13):888-9. PubMed ID: 16818851
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remarks by the Commissioner of Food and Drugs at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Kessler DA
    Food Drug Law J; 1996; 51(4):501-3. PubMed ID: 11797727
    [No Abstract]   [Full Text] [Related]  

  • 16. Food and Drug Administration Modernization Act of 1997; list of documents issued by the Food and Drug Administration that apply to medical devices regulated by the Center for Biologics Evaluation and Research. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Apr; 64(79):20312-3. PubMed ID: 10558481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarks by the Honorable Paul Rogers at the twentieth anniversary celebration of the 1976 Medical Device Amendments.
    Rogers PG
    Food Drug Law J; 1996; 51(4):505-7. PubMed ID: 11797728
    [No Abstract]   [Full Text] [Related]  

  • 18. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. W.R. Grace division under FDA fire--again.
    Burns J
    Mod Healthc; 1995 Apr; 25(16):9. PubMed ID: 10141539
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increased support for drug evaluation].
    Lakartidningen; 1969 Jan; 66(4):322-3. PubMed ID: 5818700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.